Stop the war!

Остановите войну!

for scientists:

default search action

combined dblp search
author search
venue search
publication search

ask others

Narine Sarvazyan

Name: dblp XML data dump
Creator: Schloss Dagstuhl - Leibniz Center for Informatics
Published: 1993
License: https://creativecommons.org/publicdomain/zero/1.0/
Keywords: dblp, XML, computer science, scholarly publications, metadata

◀ ▶ joint publications with Huda Asfour

> Home > Persons > Narine Sarvazyan

Publications

2018
[c2]
- view
  authority control:
- export record
  dblp key:
  - conf/mibam/GuanLASM18
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/conf/mibam/GuanLASM18
Shuyue Guan, Murray H. Loew, Huda Asfour, Narine Sarvazyan, Narine Muselimyan:
Lesion detection for cardiac ablation from auto-fluorescence hyperspectral images. Medical Imaging: Biomedical Applications in Molecular, Structural, and Functional Imaging 2018: 105781O
2011
[j1]
- view
  authority control:
- export record
  dblp key:
  - journals/tbe/AsfourSSDK11
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/tbe/AsfourSSDK11
Huda Asfour, Luther M. Swift, Narine Sarvazyan, Milos Doroslovacki, Matthew W. Kay:
Signal Decomposition of Transmembrane Voltage-Sensitive Dye Fluorescence Using a Multiresolution Wavelet Analysis. IEEE Trans. Biomed. Eng. 58(7): 2083-2093 (2011)
[c1]
- view
  authority control:
- export record
  dblp key:
  - conf/embc/AsfourSSDK11
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/conf/embc/AsfourSSDK11
Huda Asfour, Luther M. Swift, Narine Sarvazyan, Milos Doroslovacki, Matthew W. Kay:
Preprocessing of fluoresced transmembrane potential signals for cardiac optical mapping. EMBC 2011: 227-230

a service of

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.